Domin B A, Mahony W B, Zimmerman T P
Division of Experimental Therapy, Wellcome Research Laboratories, Research Triangle Park, NC 27709.
Biochem Pharmacol. 1993 Aug 17;46(4):725-9. doi: 10.1016/0006-2952(93)90560-j.
The mechanism of membrane permeation of several 2',3'-dideoxynucleosides was investigated at 37 degrees with human erythrocytes using an "inhibitor-stop" assay. Transport (per 5 microL cells) via the nucleoside and nucleobase carriers was assessed by inhibition of influx with dilazep and adenine, respectively. Mechanisms of cellular entry were highly individualized: 2',3'-dideoxyadenosine and 3'-deoxythymidin-2'-ene via nonfacilitated diffusion, with high rates; 2',3'-dideoxyguanosine mainly via the nucleobase carrier (Km = 390 microM, Vmax = 32 pmol/sec); 2',3'-dideoxyinosine by both nucleobase (Km = 850 microM, Vmax = 2.7 pmol/sec) and nucleoside (Km = 7.4 mM, Vmax = 16 pmol/sec) carriers, with a low rate of nonfacilitated diffusion; and 2',3'-dideoxycytidine, equally by the nucleoside carrier (Km = 23 mM, Vmax = 65 pmol/sec) and by nonfacilitated diffusion, with a low rate. These results demonstrate that the nucleobase carrier plays an important role in the influx of two of these dideoxynucleotides and that nonfacilitated diffusion is not necessarily the chief mode of membrane permeation of this class of drugs.
利用“抑制剂阻断”试验,在37℃条件下用人红细胞研究了几种2',3'-双脱氧核苷的膜渗透机制。分别通过双嘧达莫和腺嘌呤对流入的抑制作用,评估经由核苷和核碱基载体的转运(每5微升细胞)。细胞进入机制高度个体化:2',3'-双脱氧腺苷和3'-脱氧胸苷-2'-烯通过非易化扩散,速率较高;2',3'-双脱氧鸟苷主要通过核碱基载体(Km = 390微摩尔,Vmax = 32皮摩尔/秒);2',3'-双脱氧肌苷通过核碱基(Km = 850微摩尔,Vmax = 2.7皮摩尔/秒)和核苷(Km = 7.4毫摩尔,Vmax = 16皮摩尔/秒)载体,非易化扩散速率较低;2',3'-双脱氧胞苷通过核苷载体(Km = 23毫摩尔,Vmax = 65皮摩尔/秒)和非易化扩散的程度相同,速率较低。这些结果表明,核碱基载体在这些双脱氧核苷酸中的两种的流入中起重要作用,并且非易化扩散不一定是这类药物的主要膜渗透模式。